Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. (FRX.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FRX.TO · as of Jun 8, 2026
Key Statistics
Explore Fennec Pharmaceuticals Inc. Data
frx.to stock data · financialsAbout Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of pl…
what is fennec pharmaceuticals inc. · frx.to stock overview · fennec pharmaceuticals inc. company profile · who is fennec pharmaceuticals inc. ceo · frx.to TSX · fennec pharmaceuticals inc. headquarters · fennec pharmaceuticals inc. business segments
About Stock Overview & Key Data
Fennec Pharmaceuticals Inc. (FRX.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Jun 12, 2001. As of the latest trading session, FRX.TO stock price is $12.72, with a market capitalization of $363.5M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Fennec Pharmaceuticals Inc. (FRX.TO) stock price is $12.72. The stock is traded on TSX under the ticker symbol FRX.TO. The 52-week range is $7.59 – $14.24.